A Phase II Trial of Erlotinib Monotherapy in Pretreated Patients with Advanced Non-small Cell Lung Cancer Who Do Not Possess Active EGFR Mutations: Okayama Lung Cancer Study Group Trial 0705

Autor: Yoshioka, Hiroshige, Hotta, Katsuyuki, Kiura, Katsuyuki, Takigawa, Nagio, Hayashi, Hidetoshi, Harita, Shingo, Kuyama, Shoichi, Segawa, Yoshihiko, Kamei, Haruhito, Umemura, Shigeki, Bessho, Akihiro, Tabata, Masahiro, Tanimoto, Mitsune
Zdroj: In Journal of Thoracic Oncology January 2010 5(1):99-104
Databáze: ScienceDirect